Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
30.78
-0.02 (-0.06%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edgewise Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 28.87 | 23.45 | 17.63 | 11.03 | 2.21 | 1.3 |
| Research & Development | 118.28 | 90.91 | 54.03 | 32.19 | 14.98 | 8.62 |
| Operating Expenses | 147.15 | 114.36 | 71.66 | 43.22 | 17.19 | 9.92 |
| Operating Income | -147.15 | -114.36 | -71.66 | -43.22 | -17.19 | -9.92 |
| Interest & Investment Income | 22.86 | 14.19 | 4.02 | 0.4 | 0.07 | 0.22 |
| Pretax Income | -124.29 | -100.16 | -67.64 | -42.81 | -17.12 | -9.71 |
| Net Income | -124.29 | -100.16 | -67.64 | -42.81 | -17.12 | -9.71 |
| Net Income to Common | -124.29 | -100.16 | -67.64 | -42.81 | -17.12 | -9.71 |
| Shares Outstanding (Basic) | 85 | 64 | 54 | 38 | 1 | 0 |
| Shares Outstanding (Diluted) | 85 | 64 | 54 | 38 | 1 | 0 |
| Shares Change (YoY) | 34.04% | 18.90% | 42.82% | 4977.96% | 95.63% | - |
| EPS (Basic) | -1.46 | -1.57 | -1.26 | -1.14 | -23.17 | -25.69 |
| EPS (Diluted) | -1.46 | -1.57 | -1.26 | -1.14 | -23.17 | -25.69 |
| Free Cash Flow | -110.1 | -97.69 | -58.18 | -34.18 | -14.84 | -9.35 |
| Free Cash Flow Per Share | -1.30 | -1.53 | -1.09 | -0.91 | -20.08 | -24.75 |
| EBITDA | -145.18 | -112.81 | -71.29 | -42.94 | -17.01 | -9.8 |
| D&A For EBITDA | 1.98 | 1.55 | 0.37 | 0.27 | 0.19 | 0.12 |
| EBIT | -147.15 | -114.36 | -71.66 | -43.22 | -17.19 | -9.92 |
Source: S&P Capital IQ. Standard template.
Financial Sources.